Friday, May 7, 2010

• Presentation of Two Research Reports Involving Daxor's Blood Volume Analyzer at the 32nd Annual Meeting of the Society of Cardiovascular Anesthesiologists: Direct Blood Volume Measurement Showed Great --- NEW YORK, NY
  Posted at 6:30 AM
  

  NEW YORK, NY -- (Marketwire) -- 05/07/10 -- Daxor Corporation (NYSE Amex: DXR), a medical instrumentation and biotechnology company, today announced that two research reports were presented at the 32nd annual Society of Cardiovascular Anesthesiologists (SCA) conference in New Orleans, LA which involved the Daxor Blood Volume Analyzer (BVA-100). The BVA-100 enables measurement of whole blood volume, including plasma volume and red blood cell volume. The Principal Investigator for these studies was Mark Nelson, MD, from the Virginia Commonwealth ... read more